Agzul n yisemli ASEM
Official National Advisory Committee on Immunization document (2022) on “Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine”. What you need to know: NACI summary of recommendations for use of the recombinant protein subunit COVID-19 vaccine Novavax Nuvaxovid.
Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.
Isemli unṣib